Search Results

You are looking at 1 - 1 of 1 items for

  • Author: Nigel G Wreford x
  • Refine by access: All content x
Clear All Modify Search
Sarah J Meachem Prince Henry’s Institute of Medical Research Block E, Level 4, Monash Medical Centre, 246 Clayton Road, Clayton, Victoria 3168, Australia
Department of Anatomy and Cell Biology, Monash University, Clayton, Victoria 3168, Australia

Search for other papers by Sarah J Meachem in
Google Scholar
PubMed
Close
,
David M Robertson Prince Henry’s Institute of Medical Research Block E, Level 4, Monash Medical Centre, 246 Clayton Road, Clayton, Victoria 3168, Australia
Department of Anatomy and Cell Biology, Monash University, Clayton, Victoria 3168, Australia

Search for other papers by David M Robertson in
Google Scholar
PubMed
Close
,
Nigel G Wreford Prince Henry’s Institute of Medical Research Block E, Level 4, Monash Medical Centre, 246 Clayton Road, Clayton, Victoria 3168, Australia
Department of Anatomy and Cell Biology, Monash University, Clayton, Victoria 3168, Australia

Search for other papers by Nigel G Wreford in
Google Scholar
PubMed
Close
,
Robert I McLachlan Prince Henry’s Institute of Medical Research Block E, Level 4, Monash Medical Centre, 246 Clayton Road, Clayton, Victoria 3168, Australia
Department of Anatomy and Cell Biology, Monash University, Clayton, Victoria 3168, Australia

Search for other papers by Robert I McLachlan in
Google Scholar
PubMed
Close
, and
Peter G Stanton Prince Henry’s Institute of Medical Research Block E, Level 4, Monash Medical Centre, 246 Clayton Road, Clayton, Victoria 3168, Australia
Department of Anatomy and Cell Biology, Monash University, Clayton, Victoria 3168, Australia

Search for other papers by Peter G Stanton in
Google Scholar
PubMed
Close

Oestrogen is a metabolite of testosterone, but its role in spermatogenesis is ill-defined. Oestrogen may exert its effects on spermatogenesis, as oestrogen receptor (ER)-β has been localised to both germ and somatic cells. This study sought to establish whether the restoration of early germ cell numbers in spermatogenesis by high-dose exogenous testosterone was influenced by its metabolite, oestrogen. The ER antagonist (ICI 182780) was administered, at a dose known to impair oestrogen action in the male reproductive tract, during testosterone treatment of gonadotrophin-releasing hormone (GnRH)-immunised rats, and germ cell numbers were determined. GnRH-immunised adult Sprague–Dawley rats (n=7–8 per group) received two doses of testosterone, either as a Silastic implant (24 cm (T24 cm)) or an injectable ester for 10 days alone or in combination with ICI 182780 (2 mg/kg, s.c. injection daily). Control rats received vehicle alone. Testes were perfusion-fixed and germ cells were quantified by the optical disector technique.

GnRH-immunisation reduced (P<0.001) both type A/ intermediate spermatogonial and type B spermatogonial/ preleptotene spermatocyte number (56% of control) and leptotene/zygotene spermatocyte number (63% of control). Pachytene spermatocyte and round spermatids were reduced to 12% and l% (P<0.01) of control respectively. Testosterone treatment did not increase type A/intermediate spermatogonial number compared with GnRH-immunised controls over the 10-day study period. Treatment with testosterone-esters increased type B spermatogonial/preleptotene spermatocytes and leptotene/zygotene spermatocyte numbers (both being ~83% of control, P<0.05), while T24 cm treatment did not significantly increase their numbers (~73% of control) compared with GnRH-immunised controls. Both treatments increased pachytene spermatocyte and round spermatid numbers to 55% and 8% of control respectively. Co-administration of ICI 182780 had no effect on any of these germ cell numbers. We conclude that oestrogen action plays no role in the short-term restoration of spermatogenesis by testosterone in the GnRH-immunised rat.

Free access